ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 55 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,186,000 | +42.4% | 726,236 | +20.5% | 0.55% | +41.6% |
| Q2 2021 | $10,663,000 | -29.3% | 602,758 | -2.1% | 0.39% | -28.5% |
| Q1 2021 | $15,080,000 | -14.7% | 615,511 | +17.8% | 0.54% | -7.3% |
| Q4 2020 | $17,680,000 | +117.8% | 522,302 | +60.9% | 0.59% | +75.7% |
| Q3 2020 | $8,118,000 | +29.3% | 324,582 | +74.4% | 0.33% | +21.9% |
| Q2 2020 | $6,279,000 | – | 186,140 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |